Lower blepharoplasty fat removal vs repositioning vs grafting
Lower-eyelid fat can be selectively removed, left in place, repositioned on a pedicle, or supplemented with grafted fat. First distinguish a true fat bulge from a tear-trough hollow, edema, festoon, skin change, lid laxity, and midface anatomy.
Lower-blepharoplasty fat removal, fat repositioning, and fat grafting solve different contour problems. Removal subtracts selected orbital fat; repositioning moves vascularized fat on a pedicle to soften an adjacent hollow; grafting transfers separately harvested fat to add volume. A person can need subtraction, redistribution, addition, a combination, or none—after bags, hollows, edema, festoons, skin, lid support, and midface anatomy are distinguished.14
The incision route does not determine the fat strategy. Both transconjunctival and transcutaneous access can support different maneuvers, depending on anatomy and surgeon plan.1
Map projection and depression separately
| Finding | Possible tissue explanation | Why one fat maneuver may miss it |
|---|---|---|
| Lower-lid bag | Projecting orbital fat, lax support, fluid, skin/muscle or combinations | Removing fat may not correct laxity, edema, or a festoon |
| Tear-trough hollow | Ligament/bone contour, thin tissue, volume transition | Removing nearby fat can deepen the hollow |
| Lid-cheek groove | Transition among fat compartments, support and midface position | Repositioning may not address cheek descent or skin quality |
| Malar mound/festoon | Skin/muscle laxity, fluid and cheek-junction anatomy | Orbital-fat surgery does not automatically remove a festoon |
| Darkness | Shadow, pigment, vessels, thin skin or contour | Changing fat helps only the contour component |
| Loose or crepey skin | Skin quality and redundancy | Volume change alone may leave or worsen surface concerns |
Standardized frontal, oblique, profile, upgaze, downgaze, smiling, and neutral photographs help expose the components. Prior filler, surgery, energy treatment, trauma, thyroid eye disease, dry eye, allergies, and fluctuating swelling belong in the history.
Removal is a selective subtraction plan
Traditional bag reduction often involved excising orbital fat. Modern plans may still remove a clearly excessive compartment, but “take all the fat” is not a useful endpoint. Excessive subtraction can create or worsen a skeletonized, hollow, or sharply demarcated lid-cheek transition.4
Ask which fat compartments project, how much is expected to remain, and what stops further removal. The surgeon should explain how the plan accounts for aging and asymmetry without promising that retained fat will prevent all future hollowing.
The operative record should distinguish fat excised from tissue repositioned. Pathology handling, weights or estimates, and photographs may be used according to practice, but a gram number alone does not prove the final contour.
Repositioning moves connected tissue
Fat repositioning releases selected orbital fat while maintaining a pedicle, then places it across or beneath the orbital-rim transition. It aims to use an existing bulge to soften an adjacent depression. Technique names vary by plane, fixation, and route.
Ask:
- which compartments supply the pedicle;
- where the release occurs;
- whether tissue passes above or below named planes;
- where and how it is secured;
- how tension, irregularity, and asymmetry are controlled; and
- what happens when there is not enough suitable fat to fill the hollow.
Repositioning is not “free filler.” It adds dissection and can have swelling, contour, sensory, lid-position, and healing tradeoffs. The 2025 systematic review finds multiple approaches but limited rigorous comparative evidence.1
Grafting imports a separate volume source
Fat grafting harvests and processes fat from another site, then places small amounts in selected planes. Unlike a pedicled transposition, grafted fat is separated from its original blood supply and must integrate. Retention can vary, and contour may change with healing and weight.
The plan should identify donor site, harvest method, processing, injection planes, amount, staging, and how lumps, asymmetry, over- or under-correction, prolonged swelling, or need for revision are handled. “Stem-cell fat” or “regenerative” claims require separate product and evidence scrutiny; ordinary autologous grafting should not be marketed through unverified cell claims.
Grafting can complement removal or repositioning rather than replace them. A surgeon may selectively reduce one compartment, reposition another, and graft a different hollow. That is why one-word quote labels are hard to compare.
Access route and fat strategy are independent axes
The transconjunctival versus transcutaneous guide owns the incision decision. A transconjunctival approach reaches fat from inside the lid and avoids an external skin incision; a transcutaneous approach can provide direct skin-muscle access. Either label still leaves fat, support, skin, and resurfacing choices open.
Build a two-axis plan:
- Access: inside lid, skin incision, or combined.
- Maneuvers: remove, preserve, reposition, graft, tighten support, remove skin, treat muscle, resurface, or stage.
This prevents a clinic from presenting “scarless fat repositioning” as a complete operation when support or skin work is also proposed.
Evidence favors anatomy-based planning, not a universal winner
The recent systematic review includes excision, transposition, and grafting studies but finds inconsistent outcome definitions and limited high-level comparison.1 A 2026 retrospective series shows one combined selective-excision and repositioning strategy in chosen patients; it cannot establish superiority for all anatomy.2 The broader safety review likewise documents heterogeneous techniques and reporting.3
Ask whether cited results match primary or revision cases, age and lid support, the same approach and maneuver, follow-up, standardized photography, patient-reported outcomes, and concurrent canthal or skin procedures.
“Preservation is modern” and “removal lasts longer” are slogans, not evidence summaries.
Lid support and ocular surface can override the volume plan
Removing or moving fat changes tissue relationships but does not correct every lax or malpositioned lower lid. Canthopexy, canthoplasty, midface support, or another maneuver may be discussed. Each should have its own indication and consent.
Dry eye, closure, tear distribution, globe position, prior eye surgery, and facial nerve function affect planning. Ask who evaluates those factors and manages worsening dryness, exposure, double vision, severe pain, or visual change. The dry-eye evaluation guide supplies a record checklist.
Compare photos and quotes by component
Before-and-after images should disclose incision, fat strategy, skin/muscle work, canthal support, graft donor site, resurfacing, filler, time point, and revisions. Lighting and gaze can hide hollows or swelling.
Normalize surgeon, facility, anesthesia, access, compartment-specific maneuvers, donor-site care, adjuncts, eye care, follow-up, and revision terms. A “lower bleph” price is not comparable if the underlying operations differ.
- Draw the feature map Separate each bulge, hollow, groove, edema/festoon, skin change, pigment, and support issue.
- Choose maneuvers by compartment For each fat pad and hollow, record preserve, remove, reposition, graft, or no treatment—and why.
- Add access and support Document incision route, skin/muscle work, canthal plan, ocular-surface evaluation, and adjuncts independently.
- Audit evidence and images Require comparable anatomy, exact technique, all concurrent procedures, standardized views, follow-up, and complications.
- Assign revision ownership Clarify management and fees for hollowing, persistent bag, irregularity, fat survival, lid position, dryness, and asymmetry.
Map subtraction, movement, and addition
Ask: “Which contour is excess and which is deficient, and for each compartment are you removing, moving, or adding fat?” A plan that answers only “fat repositioning” has not yet mapped the lower eyelid.
Sources
- PubMed. Fat management in lower blepharoplasty: 2025 systematic review. Current review of excision, transposition, and grafting approaches, outcomes, access routes, and reporting limitations. Accessed .
- PubMed. Selective deep-fat excision with repositioning: 2026 series. Recent selected-patient series illustrating combined subtraction and redistribution without proving universal superiority. Accessed .
- PubMed. Lower blepharoplasty safety: 2025 systematic review. Current complication profile and evidence-quality boundary across heterogeneous lower-lid techniques. Accessed .
- PubMed Central. Lower blepharoplasty and tear-trough management: evidence overview. Anatomical overview distinguishing resection, transposition, and augmentation and the hollowing risk of excessive subtraction. Accessed .